ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Female Contraception Drug Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-2D7515
Home | Market Reports | Health| Reproductive Health
Global Female Contraception Drug Market Insights Forecast to 2028
BUY CHAPTERS

Global Female Contraception Drug Market Research Report 2025

Code: QYRE-Auto-2D7515
Report
September 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Addex Therapeutics Ltd
Agile Therapeutics Inc
Bayer
Evofem Inc
Hervana Ltd
Mithra Pharmaceuticals SA
Orbis Biosciences Inc
Teva Pharmaceutical Industries Ltd
Viramal Ltd

Female Contraception Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Female Contraception Drug Market

Female Contraception Drug Market

The global market for Female Contraception Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Female Contraception Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Female Contraception Drug.
The Female Contraception Drug market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Female Contraception Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Female Contraception Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Female Contraception Drug Market Report

Report Metric Details
Report Name Female Contraception Drug Market
CAGR 5%
Segment by Type
Segment by Application
  • Clinic
  • Hospital
  • Homecare
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Addex Therapeutics Ltd, Agile Therapeutics Inc, Bayer AG, Evofem Inc, Hervana Ltd, Mithra Pharmaceuticals SA, Orbis Biosciences Inc, Teva Pharmaceutical Industries Ltd, Viramal Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Female Contraception Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Female Contraception Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Female Contraception Drug Market report?

Ans: The main players in the Female Contraception Drug Market are Addex Therapeutics Ltd, Agile Therapeutics Inc, Bayer AG, Evofem Inc, Hervana Ltd, Mithra Pharmaceuticals SA, Orbis Biosciences Inc, Teva Pharmaceutical Industries Ltd, Viramal Ltd

What are the Application segmentation covered in the Female Contraception Drug Market report?

Ans: The Applications covered in the Female Contraception Drug Market report are Clinic, Hospital, Homecare

What are the Type segmentation covered in the Female Contraception Drug Market report?

Ans: The Types covered in the Female Contraception Drug Market report are AG-890, Amphora, BAY-1007626, Drospirenone, Others

Recommended Reports

Female Health Drugs

Drug Testing Markets

Pharmaceutical Services

1 Female Contraception Drug Market Overview
1.1 Product Definition
1.2 Female Contraception Drug by Type
1.2.1 Global Female Contraception Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 AG-890
1.2.3 Amphora
1.2.4 BAY-1007626
1.2.5 Drospirenone
1.2.6 Others
1.3 Female Contraception Drug by Application
1.3.1 Global Female Contraception Drug Market Value by Application (2024 VS 2031)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Homecare
1.4 Global Female Contraception Drug Market Size Estimates and Forecasts
1.4.1 Global Female Contraception Drug Revenue 2020-2031
1.4.2 Global Female Contraception Drug Sales 2020-2031
1.4.3 Global Female Contraception Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Female Contraception Drug Market Competition by Manufacturers
2.1 Global Female Contraception Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Female Contraception Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Female Contraception Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Female Contraception Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Female Contraception Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Female Contraception Drug, Product Type & Application
2.7 Global Key Manufacturers of Female Contraception Drug, Date of Enter into This Industry
2.8 Global Female Contraception Drug Market Competitive Situation and Trends
2.8.1 Global Female Contraception Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Female Contraception Drug Players Market Share by Revenue
2.8.3 Global Female Contraception Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Female Contraception Drug Market Scenario by Region
3.1 Global Female Contraception Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Female Contraception Drug Sales by Region: 2020-2031
3.2.1 Global Female Contraception Drug Sales by Region: 2020-2025
3.2.2 Global Female Contraception Drug Sales by Region: 2026-2031
3.3 Global Female Contraception Drug Revenue by Region: 2020-2031
3.3.1 Global Female Contraception Drug Revenue by Region: 2020-2025
3.3.2 Global Female Contraception Drug Revenue by Region: 2026-2031
3.4 North America Female Contraception Drug Market Facts & Figures by Country
3.4.1 North America Female Contraception Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Female Contraception Drug Sales by Country (2020-2031)
3.4.3 North America Female Contraception Drug Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Female Contraception Drug Market Facts & Figures by Country
3.5.1 Europe Female Contraception Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Female Contraception Drug Sales by Country (2020-2031)
3.5.3 Europe Female Contraception Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Female Contraception Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Female Contraception Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Female Contraception Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Female Contraception Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Female Contraception Drug Market Facts & Figures by Country
3.7.1 Latin America Female Contraception Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Female Contraception Drug Sales by Country (2020-2031)
3.7.3 Latin America Female Contraception Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Female Contraception Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Female Contraception Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Female Contraception Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Female Contraception Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Female Contraception Drug Sales by Type (2020-2031)
4.1.1 Global Female Contraception Drug Sales by Type (2020-2025)
4.1.2 Global Female Contraception Drug Sales by Type (2026-2031)
4.1.3 Global Female Contraception Drug Sales Market Share by Type (2020-2031)
4.2 Global Female Contraception Drug Revenue by Type (2020-2031)
4.2.1 Global Female Contraception Drug Revenue by Type (2020-2025)
4.2.2 Global Female Contraception Drug Revenue by Type (2026-2031)
4.2.3 Global Female Contraception Drug Revenue Market Share by Type (2020-2031)
4.3 Global Female Contraception Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Female Contraception Drug Sales by Application (2020-2031)
5.1.1 Global Female Contraception Drug Sales by Application (2020-2025)
5.1.2 Global Female Contraception Drug Sales by Application (2026-2031)
5.1.3 Global Female Contraception Drug Sales Market Share by Application (2020-2031)
5.2 Global Female Contraception Drug Revenue by Application (2020-2031)
5.2.1 Global Female Contraception Drug Revenue by Application (2020-2025)
5.2.2 Global Female Contraception Drug Revenue by Application (2026-2031)
5.2.3 Global Female Contraception Drug Revenue Market Share by Application (2020-2031)
5.3 Global Female Contraception Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Addex Therapeutics Ltd
6.1.1 Addex Therapeutics Ltd Company Information
6.1.2 Addex Therapeutics Ltd Description and Business Overview
6.1.3 Addex Therapeutics Ltd Female Contraception Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Addex Therapeutics Ltd Female Contraception Drug Product Portfolio
6.1.5 Addex Therapeutics Ltd Recent Developments/Updates
6.2 Agile Therapeutics Inc
6.2.1 Agile Therapeutics Inc Company Information
6.2.2 Agile Therapeutics Inc Description and Business Overview
6.2.3 Agile Therapeutics Inc Female Contraception Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Agile Therapeutics Inc Female Contraception Drug Product Portfolio
6.2.5 Agile Therapeutics Inc Recent Developments/Updates
6.3 Bayer AG
6.3.1 Bayer AG Company Information
6.3.2 Bayer AG Description and Business Overview
6.3.3 Bayer AG Female Contraception Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bayer AG Female Contraception Drug Product Portfolio
6.3.5 Bayer AG Recent Developments/Updates
6.4 Evofem Inc
6.4.1 Evofem Inc Company Information
6.4.2 Evofem Inc Description and Business Overview
6.4.3 Evofem Inc Female Contraception Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Evofem Inc Female Contraception Drug Product Portfolio
6.4.5 Evofem Inc Recent Developments/Updates
6.5 Hervana Ltd
6.5.1 Hervana Ltd Company Information
6.5.2 Hervana Ltd Description and Business Overview
6.5.3 Hervana Ltd Female Contraception Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Hervana Ltd Female Contraception Drug Product Portfolio
6.5.5 Hervana Ltd Recent Developments/Updates
6.6 Mithra Pharmaceuticals SA
6.6.1 Mithra Pharmaceuticals SA Company Information
6.6.2 Mithra Pharmaceuticals SA Description and Business Overview
6.6.3 Mithra Pharmaceuticals SA Female Contraception Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Mithra Pharmaceuticals SA Female Contraception Drug Product Portfolio
6.6.5 Mithra Pharmaceuticals SA Recent Developments/Updates
6.7 Orbis Biosciences Inc
6.7.1 Orbis Biosciences Inc Company Information
6.7.2 Orbis Biosciences Inc Description and Business Overview
6.7.3 Orbis Biosciences Inc Female Contraception Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Orbis Biosciences Inc Female Contraception Drug Product Portfolio
6.7.5 Orbis Biosciences Inc Recent Developments/Updates
6.8 Teva Pharmaceutical Industries Ltd
6.8.1 Teva Pharmaceutical Industries Ltd Company Information
6.8.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.8.3 Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Teva Pharmaceutical Industries Ltd Female Contraception Drug Product Portfolio
6.8.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.9 Viramal Ltd
6.9.1 Viramal Ltd Company Information
6.9.2 Viramal Ltd Description and Business Overview
6.9.3 Viramal Ltd Female Contraception Drug Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Viramal Ltd Female Contraception Drug Product Portfolio
6.9.5 Viramal Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Female Contraception Drug Industry Chain Analysis
7.2 Female Contraception Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Female Contraception Drug Production Mode & Process Analysis
7.4 Female Contraception Drug Sales and Marketing
7.4.1 Female Contraception Drug Sales Channels
7.4.2 Female Contraception Drug Distributors
7.5 Female Contraception Drug Customer Analysis
8 Female Contraception Drug Market Dynamics
8.1 Female Contraception Drug Industry Trends
8.2 Female Contraception Drug Market Drivers
8.3 Female Contraception Drug Market Challenges
8.4 Female Contraception Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Addex Therapeutics Ltd
Agile Therapeutics Inc
Bayer
Evofem Inc
Hervana Ltd
Mithra Pharmaceuticals SA
Orbis Biosciences Inc
Teva Pharmaceutical Industries Ltd
Viramal Ltd
List of Tables
 Table 1. Global Female Contraception Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Female Contraception Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Female Contraception Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Female Contraception Drug Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Female Contraception Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Female Contraception Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Female Contraception Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Female Contraception Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Female Contraception Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Female Contraception Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Female Contraception Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Female Contraception Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Female Contraception Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Female Contraception Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Female Contraception Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Female Contraception Drug Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Female Contraception Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Female Contraception Drug Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Female Contraception Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Female Contraception Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Female Contraception Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Female Contraception Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Female Contraception Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Female Contraception Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Female Contraception Drug Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Female Contraception Drug Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Female Contraception Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Female Contraception Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Female Contraception Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Female Contraception Drug Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Female Contraception Drug Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Female Contraception Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Female Contraception Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Female Contraception Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Female Contraception Drug Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Female Contraception Drug Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Female Contraception Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Female Contraception Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Female Contraception Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Female Contraception Drug Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Female Contraception Drug Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Female Contraception Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Female Contraception Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Female Contraception Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Female Contraception Drug Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Female Contraception Drug Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Female Contraception Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Female Contraception Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Female Contraception Drug Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Female Contraception Drug Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Female Contraception Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Female Contraception Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Female Contraception Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Female Contraception Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Female Contraception Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Female Contraception Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Female Contraception Drug Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Female Contraception Drug Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Female Contraception Drug Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Female Contraception Drug Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Female Contraception Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Female Contraception Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Female Contraception Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Female Contraception Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Female Contraception Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Female Contraception Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Female Contraception Drug Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Female Contraception Drug Price (USD/Pcs) by Application (2026-2031)
 Table 70. Addex Therapeutics Ltd Company Information
 Table 71. Addex Therapeutics Ltd Description and Business Overview
 Table 72. Addex Therapeutics Ltd Female Contraception Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Addex Therapeutics Ltd Female Contraception Drug Product
 Table 74. Addex Therapeutics Ltd Recent Developments/Updates
 Table 75. Agile Therapeutics Inc Company Information
 Table 76. Agile Therapeutics Inc Description and Business Overview
 Table 77. Agile Therapeutics Inc Female Contraception Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Agile Therapeutics Inc Female Contraception Drug Product
 Table 79. Agile Therapeutics Inc Recent Developments/Updates
 Table 80. Bayer AG Company Information
 Table 81. Bayer AG Description and Business Overview
 Table 82. Bayer AG Female Contraception Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Bayer AG Female Contraception Drug Product
 Table 84. Bayer AG Recent Developments/Updates
 Table 85. Evofem Inc Company Information
 Table 86. Evofem Inc Description and Business Overview
 Table 87. Evofem Inc Female Contraception Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Evofem Inc Female Contraception Drug Product
 Table 89. Evofem Inc Recent Developments/Updates
 Table 90. Hervana Ltd Company Information
 Table 91. Hervana Ltd Description and Business Overview
 Table 92. Hervana Ltd Female Contraception Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Hervana Ltd Female Contraception Drug Product
 Table 94. Hervana Ltd Recent Developments/Updates
 Table 95. Mithra Pharmaceuticals SA Company Information
 Table 96. Mithra Pharmaceuticals SA Description and Business Overview
 Table 97. Mithra Pharmaceuticals SA Female Contraception Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Mithra Pharmaceuticals SA Female Contraception Drug Product
 Table 99. Mithra Pharmaceuticals SA Recent Developments/Updates
 Table 100. Orbis Biosciences Inc Company Information
 Table 101. Orbis Biosciences Inc Description and Business Overview
 Table 102. Orbis Biosciences Inc Female Contraception Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Orbis Biosciences Inc Female Contraception Drug Product
 Table 104. Orbis Biosciences Inc Recent Developments/Updates
 Table 105. Teva Pharmaceutical Industries Ltd Company Information
 Table 106. Teva Pharmaceutical Industries Ltd Description and Business Overview
 Table 107. Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Teva Pharmaceutical Industries Ltd Female Contraception Drug Product
 Table 109. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
 Table 110. Viramal Ltd Company Information
 Table 111. Viramal Ltd Description and Business Overview
 Table 112. Viramal Ltd Female Contraception Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Viramal Ltd Female Contraception Drug Product
 Table 114. Viramal Ltd Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Female Contraception Drug Distributors List
 Table 118. Female Contraception Drug Customers List
 Table 119. Female Contraception Drug Market Trends
 Table 120. Female Contraception Drug Market Drivers
 Table 121. Female Contraception Drug Market Challenges
 Table 122. Female Contraception Drug Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Female Contraception Drug
 Figure 2. Global Female Contraception Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Female Contraception Drug Market Share by Type: 2024 & 2031
 Figure 4. AG-890 Product Picture
 Figure 5. Amphora Product Picture
 Figure 6. BAY-1007626 Product Picture
 Figure 7. Drospirenone Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Female Contraception Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Female Contraception Drug Market Share by Application: 2024 & 2031
 Figure 11. Clinic
 Figure 12. Hospital
 Figure 13. Homecare
 Figure 14. Global Female Contraception Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Female Contraception Drug Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Female Contraception Drug Sales (2020-2031) & (K Pcs)
 Figure 17. Global Female Contraception Drug Average Price (USD/Pcs) & (2020-2031)
 Figure 18. Female Contraception Drug Report Years Considered
 Figure 19. Female Contraception Drug Sales Share by Manufacturers in 2024
 Figure 20. Global Female Contraception Drug Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Female Contraception Drug Players: Market Share by Revenue in Female Contraception Drug in 2024
 Figure 22. Female Contraception Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Female Contraception Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Female Contraception Drug Sales Market Share by Country (2020-2031)
 Figure 25. North America Female Contraception Drug Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Female Contraception Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Female Contraception Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Female Contraception Drug Sales Market Share by Country (2020-2031)
 Figure 29. Europe Female Contraception Drug Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Female Contraception Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Female Contraception Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Female Contraception Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Female Contraception Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Female Contraception Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Female Contraception Drug Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Female Contraception Drug Revenue Market Share by Region (2020-2031)
 Figure 37. China Female Contraception Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Female Contraception Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Female Contraception Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Female Contraception Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Female Contraception Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Female Contraception Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Female Contraception Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Female Contraception Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Female Contraception Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Female Contraception Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Female Contraception Drug Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Female Contraception Drug Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Female Contraception Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Female Contraception Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Female Contraception Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Female Contraception Drug Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Female Contraception Drug Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Female Contraception Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Female Contraception Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Female Contraception Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Female Contraception Drug by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Female Contraception Drug by Type (2020-2031)
 Figure 59. Global Female Contraception Drug Price (USD/Pcs) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Female Contraception Drug by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Female Contraception Drug by Application (2020-2031)
 Figure 62. Global Female Contraception Drug Price (USD/Pcs) by Application (2020-2031)
 Figure 63. Female Contraception Drug Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Female Contraceptive Pill Market Insights Forecast to 2030
Female Oral Contraceptives Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Contraceptive Market Research Report 2024
Contraceptive Pills Market
Global Obstetrics and Gynecology Drugs Market Research Report 2025
Global Gynecological Nursing Drugs Market Research Report 2025
Global Gynecological Cancers Drug Market Research Report 2025
Global Reproductive and Fertility Diagnosis Market Research Report 2025
Global Low dose Birth Control Pill Market Research Report 2025
Woman Disease Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Weekly Pill Organizer Market Research Report 2025
Global Pregnancy Medication Market Research Report 2025
Menopause Hormonal Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Menopause Hormonal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Estrogen Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pill Organizer with Timer Reminder Market Research Report 2025
Global Drugs of Abuse Testing Market Research Report 2024
Global Pill Testing Service Market Research Report 2025
Global Cholesterol Lowering Drugs Market Research Report 2024
Global Cardiovascular Disease Nursing Drugs Market Research Report 2025

RELATED REPORTS

Global Microfluidic in Vitro Diagnostics Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24Z19487
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Yohimbe Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34B2983
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Erection Rings Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19V3238
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Sperm Bank Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35F5845
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions